Format

Send to

Choose Destination
See comment in PubMed Commons below
Histol Histopathol. 2005 Oct;20(4):1339-49. doi: 10.14670/HH-20.1339.

Hepatocyte growth factor/scatter factor and prostate cancer: a review.

Author information

1
Metastasis and Angiogenesis Research Group, Department of Surgery, Wales College of Medicine, Heath Park, Cardiff. UK. rhidian.hurle@cardiffandvale.wales.nhs.uk

Abstract

Men who die from prostate cancer do so from uncontrolled metastatic disease. A better understanding of the mechanisms involved in the progression and metastasis of prostate cancer may lead to novel therapeutic approaches to prevent its natural progression. Hepatocyte Growth Factor / Scatter factor (HGF/SF) has been demonstrated to elicit a number of key functions in numerous tissues that are important in the progression, invasion and metastasis of cancer. Studies have demonstrated that the activity of HGF/SF and its receptor c-Met are linked to disease progression in numerous cancers. However, research into these functions, which include activities as a mitogen, a motogen and an anti-apoptotic and angiogenic factor in prostate cancer are limited. This article reviews the published evidence of the roles HGF/SF plays in prostate cancer progression and highlights the clinical and therapeutic potential of research into this pleiomorphic cytokine.

PMID:
16136515
DOI:
10.14670/HH-20.1339
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Sercrisma International S.L.
    Loading ...
    Support Center